Development of new strategies for cancer treatment based in system biological-analysis of cancer system abnormality
Development of new strategies for cancer treatment based in system biological-analysis of cancer system abnormality
批准号:
15390439
负责人:
TABUCHI Kazuo
金额:
$8.96万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
本研究的目的是在对癌症系统异常进行系统生物学分析的基础上,开发新的癌症治疗策略。通过基于微阵列的比较基因组杂交,在胶质母细胞瘤细胞中发现了新的基因组异常。首次尝试以阅读方向为时间轴,对拷贝数谱进行去趋势波动分析,结果表明,较高的长期分形标度指数与胶质母细胞瘤患者较长的生存期有很好的相关性。利用SELDI-TOF MS(表面增强激光解吸/电离飞行时间质谱仪)和MALDI(基质辅助激光解吸/电离)TOF MS的蛋白质组学技术鉴定了多营养素是神经干细胞的特异性生长因子,而转甲状腺激素是脑缺血特异性蛋白。Petri网模拟表明,可溶性FasL的三聚体形成对于增强细胞的促凋亡活性是必不可少的。在胶质母细胞瘤生物分子系统中发现了冗余性、多样性、反馈、模块化和解偶性四种生物稳健性的分子机制。利用Path Assistant软件建立的分子连接网络具有无标度网络的特点,如枢纽的存在、幂定律的义务、所谓的小世界和蝴蝶结结构等。对HUB蛋白/子系统的蓄意攻击似乎很容易摧毁癌症的无标度网络。
英文摘要
The purpose of this research is to develop the new strategies of cancer treatment based on systems biological analysis of cancer system abnormality. New genomic aberrations were found in glioblastoma cells by microarray-based comparative genomic hybridization. The first attempts to apply detrended fluctuation analysis to copy number profiles by considering the reading direction as the time axis demonstrated that higher long-term fractal scaling exponents correlated well with longer survival of glioblastoma patients. Proteomic technique using both SELDI-TOF MS(surface enhanced laser desorption/ionization time-of-flight mass spectrometry) and MALDI(matrix assisted laser desorption/ionization) TOF MS identified pleiotrophin as a specific growth factor of neural stem cells and transthyretin as a brain ischemia-specific protein. Petri-Net simulation demonstrated that trimer formation of soluble FasL is essential to enhance apoptotic enhancing activity. The four molecular mechanisms of biological robustness such as redundancy, diversity, feedback, modularity and decoupling were found in glioblastoma biomolecular system. Molecular connection network established by PathwayAssist software had the characteristics of scale-free networks such as existence of hub, obligation of power law, so-called small world and bow-tie structure. The intentional attack to hub protein/subsystem seems to easily destroy the scale-free network of cancer.
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Expression of the Wilms'tumor gene product WT1 in glioblastomas and medullobalstomas
维尔姆斯肿瘤基因产物 WT1 在胶质母细胞瘤和髓母细胞瘤中的表达
DOI:
--
发表时间:
2004
期刊:
Brain Tumor Pathology 21
影响因子:
--
作者:
[Okamoto H, Mineta T, Ueda S, Nakahara Y, Shiraishi T, Tamiya T, Tabuchi K, Okamoto H., Shiraishi T, Ueda S, Nakahara Y, Nakahara Y]
通讯作者:
Nakahara Y
悪性グリオーマ発生の分子機序
恶性胶质瘤发生的分子机制
DOI:
--
发表时间:
2005
期刊:
脳外誌 14
影响因子:
--
作者:
[Malchinhuu E, Sato K, Horiuchi Y, Mogi C, Ishiuchi S et al., 田渕和雄]
通讯作者:
田渕和雄
DOI:
10.1016/j.bbrc.2004.07.098
发表时间:
2004-09-10
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
[Shiraishi, T, Suzuyama, K, Nagata, S]
通讯作者:
Nagata, S
Genetic alterations of human brain tumors as molecular prognostic factors.
人类脑肿瘤的遗传改变作为分子预后因素。
DOI:
--
发表时间:
2003
期刊:
Neuropathology 23
影响因子:
--
作者:
[Shiraishi T, Tabuchi K]
通讯作者:
Tabuchi K
Induction of the DNA repair gene MGMT by dexamethasone in glioblastomas
地塞米松在胶质母细胞瘤中诱导 DNA 修复基因 MGMT
DOI:
--
发表时间:
2004
期刊:
Journal of Neurosurgery 101
影响因子:
--
作者:
[Okamoto H, Mineta T, Ueda S, Nakahara Y, Shiraishi T, Tamiya T, Tabuchi K, Okamoto H., Shiraishi T, Ueda S]
通讯作者:
Ueda S
共 17 条
Biomarker Discovery of CSF biomarker of medulloblastoma by SELDI-TOF mass spectrometry
-
批准号:12470293
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2000
-
负责人:TABUCHI Kazuo
-
依托单位:
Analysis of apoptosis-related products in delayed neuronal death following cerebral ischemia
-
批准号:10557129
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.67万
-
财政年份:1998
-
负责人:TABUCHI Kazuo
-
依托单位:
Molecular diagnosis of glioblastomas based on genetic alterations.
-
批准号:09470298
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:1997
-
负责人:TABUCHI Kazuo
-
依托单位:
STUDY OF DNA FRAGMENTATION AND APOPTOSIS-RELATED GENE PRODUCTS IN HUMAN BRAIN TUMORS AND ESTABLISHMENT OF APOPTOSIS-INDUCING THERAPY.
-
批准号:07457319
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1995
-
负责人:TABUCHI Kazuo
-
依托单位:
STUDY ON THE DIAGNOSIS AND THERAPY OF BRAIN TUMORS IN TERMS OF GENETIC ENGINEERING
-
批准号:04454363
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1992
-
负责人:TABUCHI Kazuo
-
依托单位:
Study on Oncogenes and Growth-Related Antigens of Human Brain Tumors
-
批准号:01480551
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$0.64万
-
财政年份:1989
-
负责人:TABUCHI Kazuo
-
依托单位:
Qualitative and quantitative study of oncogene-products in gliomas.
-
批准号:60570673
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.83万
-
财政年份:1985
-
负责人:TABUCHI Kazuo
-
依托单位:
国内基金
海外基金
同时应用cDNA表达谱和Array-CGH技术研究前列腺癌雄激素敏感和耐受的转变机制
-
批准号:30371422
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2003
-
负责人:李瑶
-
依托单位: